Reported Tuberculosis in the United States, 2022

Return to Main Menu

Table 29. Tuberculosis Cases and Percentages by Pulmonary and Extrapulmonary Disease: Reporting Areas, 2022

 

Table 29. Tuberculosis cases and percentages by pulmonary and extrapulmonary disease and reporting area.
Reporting area Total cases1 Pulmonary2 Extrapulmonary3 Both pulmonary and extrapulmonary
No. (%) No. (%) No. (%)
United States4 8,314 5,864 (70.5) 1,569 (18.9) 881 (10.6)
Alabama 64 50 (78.1) 13 (20.3) 1 (1.6)
Alaska 95 78 (82.1) 11 (11.6) 6 (6.3)
Arizona 154 117 (76.0) 18 (11.7) 19 (12.3)
Arkansas 68 52 (76.5) 10 (14.7) 6 (8.8)
California 1,845 1,359 (73.7) 286 (15.5) 200 (10.8)
Colorado 57 36 (63.2) 12 (21.1) 9 (15.8)
Connecticut 66 50 (75.8) 11 (16.7) 5 (7.6)
Delaware 13 8 (61.5) 4 (30.8) 1 (7.7)
District of Columbia 15 9 (60.0) 2 (13.3) 4 (26.7)
Florida 534 425 (79.6) 78 (14.6) 31 (5.8)
Georgia 261 182 (69.7) 55 (21.1) 24 (9.2)
Hawaii 101 79 (78.2) 10 (9.9) 12 (11.9)
Idaho 11 5 (45.5) 4 (36.4) 2 (18.2)
Illinois 298 192 (64.4) 77 (25.8) 29 (9.7)
Indiana 99 66 (66.7) 18 (18.2) 15 (15.2)
Iowa 60 23 (38.3) 14 (23.3) 23 (38.3)
Kansas 52 38 (73.1) 9 (17.3) 5 (9.6)
Kentucky 70 47 (67.1) 16 (22.9) 7 (10.0)
Louisiana 95 76 (80.0) 12 (12.6) 7 (7.4)
Maine 17 11 (64.7) 3 (17.6) 3 (17.6)
Maryland 154 106 (68.8) 39 (25.3) 9 (5.8)
Massachusetts 153 84 (54.9) 45 (29.4) 24 (15.7)
Michigan 120 61 (50.8) 45 (37.5) 14 (11.7)
Minnesota 132 81 (61.4) 32 (24.2) 19 (14.4)
Mississippi 53 43 (81.1) 5 (9.4) 5 (9.4)
Missouri 69 46 (66.7) 17 (24.6) 6 (8.7)
Montana 6 4 (66.7) 2 (33.3) 0 (0.0)
Nebraska 27 16 (59.3) 10 (37.0) 1 (3.7)
Nevada 60 48 (80.0) 8 (13.3) 4 (6.7)
New Hampshire 11 6 (54.5) 3 (27.3) 2 (18.2)
New Jersey 289 227 (78.5) 44 (15.2) 18 (6.2)
New Mexico 30 18 (60.0) 9 (30.0) 3 (10.0)
New York State5 177 108 (61.0) 42 (23.7) 27 (15.3)
New York City 536 346 (64.6) 83 (15.5) 107 (20.0)
North Carolina 163 100 (61.3) 56 (34.4) 7 (4.3)
North Dakota 10 5 (50.0) 5 (50.0) 0 (0.0)
Ohio 146 102 (69.9) 42 (28.8) 2 (1.4)
Oklahoma 80 54 (67.5) 15 (18.8) 11 (13.8)
Oregon 73 39 (53.4) 21 (28.8) 13 (17.8)
Pennsylvania 173 120 (69.4) 38 (22.0) 15 (8.7)
Rhode Island 17 9 (52.9) 4 (23.5) 4 (23.5)
South Carolina 101 67 (66.3) 16 (15.8) 18 (17.8)
South Dakota 10 6 (60.0) 2 (20.0) 2 (20.0)
Tennessee 106 77 (72.6) 24 (22.6) 5 (4.7)
Texas 1,098 840 (76.5) 168 (15.3) 90 (8.2)
Utah 33 21 (63.6) 10 (30.3) 2 (6.1)
Vermont 3 1 (33.3) 2 (66.7) 0 (0.0)
Virginia 195 135 (69.2) 47 (24.1) 13 (6.7)
Washington 251 150 (59.8) 59 (23.5) 42 (16.7)
West Virginia 11 7 (63.6) 3 (27.3) 1 (9.1)
Wisconsin 51 33 (64.7) 10 (19.6) 8 (15.7)
Wyoming 1 1 (100.0) 0 (0.0) 0 (0.0)
American Samoa –– –– –– –– –– –– ––
Federated States of Micronesia 51 41 (80.4) 9 (17.6) 1 (2.0)
Guam 59 56 (94.9) 0 (0.0) 3 (5.1)
Republic of the Marshall Islands 99 73 (73.7) 24 (24.2) 2 (2.0)
Northern Mariana Islands 23 22 (95.7) 0 (0.0) 1 (4.3)
Puerto Rico 22 19 (86.4) 2 (9.1) 1 (4.5)
Republic of Palau 7 7 (100.0) 0 (0.0) 0 (0.0)
U.S. Virgin Islands –– –– –– –– –– –– ––

1Persons with a known site of disease.
2Persons with pulmonary listed as the only site of disease.
3Persons with pleural, lymphatic, bone and/or joint, meningeal, peritoneal, genitourinary, or other site, excluding pulmonary, listed as the site of disease.
4American Samoa, Federated States of Micronesia, Guam, Republic of the Marshall Islands, Northern Mariana Islands, Puerto Rico, Republic of Palau, and U.S. Virgin Islands are not included in the U.S. totals and percentages.
5Excludes New York City.

Note:
24 cases had missing and/or unknown site of disease in the United States.

Data for all years are updated through July 8, 2023.

Double dashes (––) indicate that data are not available.